chr1-33092212-C-T

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_052998.4(AZIN2):​c.442C>T​(p.Pro148Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000731 in 1,613,774 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0040 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00039 ( 4 hom. )

Consequence

AZIN2
NM_052998.4 missense

Scores

1
6
9

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 2.89

Publications

1 publications found
Variant links:
Genes affected
AZIN2 (HGNC:29957): (antizyme inhibitor 2) The protein encoded by this gene belongs to the antizyme inhibitor family, which plays a role in cell growth and proliferation by maintaining polyamine homeostasis within the cell. Antizyme inhibitors are homologs of ornithine decarboxylase (ODC, the key enzyme in polyamine biosynthesis) that have lost the ability to decarboxylase ornithine; however, retain the ability to bind to antizymes. Antizymes negatively regulate intracellular polyamine levels by binding to ODC and targeting it for degradation, as well as by inhibiting polyamine uptake. Antizyme inhibitors function as positive regulators of polyamine levels by sequestering antizymes and neutralizing their effect. This gene encodes antizyme inhibitor 2, the second member of this gene family. Like antizyme inhibitor 1, antizyme inhibitor 2 interacts with all 3 antizymes and stimulates ODC activity and polyamine uptake. However, unlike antizyme inhibitor 1, which is ubiquitously expressed and localized in the nucleus and cytoplasm, antizyme inhibitor 2 is predominantly expressed in the brain and testis and localized in the endoplasmic reticulum-golgi intermediate compartment. Recent studies indicate that antizyme inhibitor 2 is also expressed in specific cell types in ovaries, adrenal glands and pancreas, and in mast cells. The exact function of this gene is not known, however, available data suggest its role in cell growth, spermiogenesis, vesicular trafficking and secretion. Accumulation of antizyme inhibitor 2 has also been observed in brains of patients with Alzheimer's disease. There has been confusion in literature and databases over the nomenclature of this gene, stemming from an earlier report that a human cDNA clone (identical to ODCp/AZIN2) had arginine decarboxylase (ADC) activity (PMID:14738999). Subsequent studies in human and mouse showed that antizyme inhibitor 2 was devoid of arginine decarboxylase activity (PMID:19956990). Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Sep 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006093949).
BP6
Variant 1-33092212-C-T is Benign according to our data. Variant chr1-33092212-C-T is described in ClinVar as Benign. ClinVar VariationId is 791788.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_052998.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AZIN2
NM_052998.4
MANE Select
c.442C>Tp.Pro148Ser
missense
Exon 6 of 12NP_443724.1Q96A70-1
AZIN2
NM_001301825.1
c.442C>Tp.Pro148Ser
missense
Exon 3 of 9NP_001288754.1Q96A70-2
AZIN2
NM_001293562.2
c.442C>Tp.Pro148Ser
missense
Exon 5 of 11NP_001280491.1Q96A70-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AZIN2
ENST00000294517.11
TSL:1 MANE Select
c.442C>Tp.Pro148Ser
missense
Exon 6 of 12ENSP00000294517.6Q96A70-1
AZIN2
ENST00000373441.1
TSL:1
c.442C>Tp.Pro148Ser
missense
Exon 3 of 9ENSP00000362540.1Q96A70-2
AZIN2
ENST00000373443.7
TSL:1
c.442C>Tp.Pro148Ser
missense
Exon 5 of 11ENSP00000362542.3Q96A70-1

Frequencies

GnomAD3 genomes
AF:
0.00400
AC:
608
AN:
152072
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0141
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000958
GnomAD2 exomes
AF:
0.00105
AC:
264
AN:
250940
AF XY:
0.000744
show subpopulations
Gnomad AFR exome
AF:
0.0148
Gnomad AMR exome
AF:
0.000579
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.000327
GnomAD4 exome
AF:
0.000391
AC:
571
AN:
1461584
Hom.:
4
Cov.:
31
AF XY:
0.000338
AC XY:
246
AN XY:
727102
show subpopulations
African (AFR)
AF:
0.0142
AC:
475
AN:
33476
American (AMR)
AF:
0.000626
AC:
28
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26114
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86216
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53408
Middle Eastern (MID)
AF:
0.000698
AC:
4
AN:
5730
European-Non Finnish (NFE)
AF:
0.00000720
AC:
8
AN:
1111856
Other (OTH)
AF:
0.000878
AC:
53
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
32
64
97
129
161
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00400
AC:
609
AN:
152190
Hom.:
7
Cov.:
32
AF XY:
0.00386
AC XY:
287
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.0141
AC:
586
AN:
41468
American (AMR)
AF:
0.00131
AC:
20
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68024
Other (OTH)
AF:
0.000948
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
28
57
85
114
142
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00155
Hom.:
3
Bravo
AF:
0.00446
ESP6500AA
AF:
0.0104
AC:
46
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00131
AC:
159
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.50
D
Eigen
Benign
0.15
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.74
T
MetaRNN
Benign
0.0061
T
MetaSVM
Benign
-0.75
T
PhyloP100
2.9
PrimateAI
Benign
0.34
T
PROVEAN
Pathogenic
-6.5
D
REVEL
Benign
0.25
Sift
Uncertain
0.017
D
Sift4G
Uncertain
0.030
D
Polyphen
0.24
B
Vest4
0.28
MVP
0.17
MPC
0.19
ClinPred
0.042
T
GERP RS
4.5
Varity_R
0.45
gMVP
0.53
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151245414; hg19: chr1-33557813; COSMIC: COSV99037681; COSMIC: COSV99037681; API